Ono seeking Japanese approval of nivolumab

Ono Pharmaceutical Co. Ltd. (Tokyo:4528) submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for nivolumab ( BMS-936558) to treat malignant melanoma. Ono said regulatory applicati...